Background: Infections are a major cause of mortality and morbidity in pediatric ALL patients especially during induction chemotherapy. We present the profile of infections among 227 consecutive patients who presented with ALL during an 18-month period. Information on the clinical and microbiological profile of infections is very important in the counseling, management and prognostication of patients with ALL. Objective: To describe the clinical and microbiological profile, treatment and outcome of infections during induction chemotherapy in children with ALL. Method: This was a prospective observational study. All children (Age: 1 e 14 years) newly diagnosed to have ALL and seeking the services of the Pediatric oncology division at our Center during the study period were included. Induction chemotherapy was administered as per a modified BFM protocol, for all. Observations: 227 patients (144 belonged to high risk category and 83 belonged to standard risk category) were enrolled during the study period (January 2014 to June 2015). There were 150 episodes of infection which occurred among 117 patients. Major sites were lung (n¼35) and GIT (n¼30). No definite focus of infection was evident in 28%. Blood cultures were positive in 45 episodes (30.6%). Isolates were gram negative organisms (n¼36; 80%) in the majority in whom culture was positive. Five of the isolates were fungal out of which two were in combination with Pseudomonas. 127 episodes were initially treated with first line antibiotics, 19 episodes with second line antibiotics and 4 episodes with third line antibiotics based upon the severity of infection. Eventually, 127 episodes received first line, 47 episodes received second line and 28 episodes received third line antibiotics as per institutional protocol. Antifungals were given in 29 episodes (19.3%). 24 among them were empirical and the rest based on positive culture reports. Intensive supportive care in the form of inotropes or mechanical ventilation was required in 17 episodes (11.3%). One hundred and thirty six (90.6%) episodes resolved without sequelae. Twelve patients (8%) died (One of them had varicella with hepatitis and Abstracts / Pediatric Hematology Oncology Journal 1 (2016) S1eS33 S11
